MAI [Market Access Intelligence]

Glade AI is building an agentic platform to help pharma and biotech teams make smarter pricing and access decisions. Our tool lets teams simulate rebate strategies, forecast gross-to-net, and stress-test launch plans — without relying solely on spreadsheets or consultants. Market access is full of complex choices: how much to rebate, which contracts to prioritize, how payers might respond. We’re giving teams a faster, smarter way to model those trade-offs — using an agentic AI system built specifically for pricing and market access workflows. We’re working with early partners prepping for U.S. launch, renegotiating payer contracts, or navigating high-stakes therapeutic areas. 🚀 Interested in early access? Apply Join our Alpha Partner Cohort: https://tally.so/r/3l9VjX